As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
Diasens and GlucoLive are designed for diabetic, Chronic Kidney Disease (CKD), and post-transplant patients who require continuous glycaemic surveillance and integrated remote care
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
The clearance marks a major step in Diabeloop’s ambition to become a central partner for insulin pump manufacturers and expand access to automated insulin delivery in the US market
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
This predictive technology empowers people with diabetes to take preventive action before complications arise
Now integrates with Abbott’s instinct sensor and approved for type 2 diabetes
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
